These factors typically resolve within 24 weeks as your body acclimates to the medication and you establish a sustainable eating pattern
Whos Using GLP-1s and Why According to the survey, 1 in 10 adults currently use a GLP-1 medication, and a further 42% say theyve seriously considered starting treatment
This translates to better recovery, improved body composition, and sustained energy
When you eat beyond this new appetite threshold, your GI tract sends exaggerated fullness signals
This effect is probably a consequence of the increased baseline expression of caspase-1 and perhaps other inflammasome-associated factors, such as Gasdermins C2 and C3 that can act as terminal effectors of inflammatory cell lysis 27 , which were observed here in vitro and were previously described in ex vivo proteomics studies of mouse urothelia 8
doi: 10.1007/s00394-013-0511-0